SCHEMBL4826427

SCHEMBL4826427

C=C(C(=O)c1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 8/20 0.68
CES1 P23141 7/20 0.68
MAPT P10636 5/20 0.59
ALDH1A1 P00352 4/20 0.59
LMNA P02545 3/20 0.58
NPSR1 Q6W5P4 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
XBP1 P17861 1/20 0.58
ATM Q13315 1/20 0.58
POLB P06746 2/20 0.54
USP2 O75604 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
TSHR P16473 2/20 0.52
DAO P14920 1/20 0.52
NAPRT Q6XQN6 1/20 0.52
EGFR P00533 2/20 0.52
AKT1 P31749 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9419968 0.97 CES2 (0.65) CES2CES1MAPTALDH1A1LMNA
SCHEMBL491263 0.90 CES2 (0.62) CES2CES1MAPTALDH1A1LMNA
SCHEMBL8120050 0.87 CES2 (0.59) CES2CES1MAPTALDH1A1LMNA
SCHEMBL3101206 0.85 CES2 (0.56) CES2CES1MAPTALDH1A1LMNA
SCHEMBL14886367 0.85 CES2 (0.67) CES2CES1MAPTALDH1A1LMNA
SCHEMBL9861745 0.84 CES2 (0.54) CES2CES1MAPTALDH1A1LMNA
SCHEMBL27864542 0.84 MAPT (0.65) CES2CES1MAPTALDH1A1LMNA
Lithium Ion SCHEMBL8120046 0.84 CES2 (0.54) CES2CES1MAPTALDH1A1LMNA
SCHEMBL45539 0.83 CES2 (0.68) CES2CES1MAPTALDH1A1LMNA
Benzil SCHEMBL8382614 0.82 CES2 (0.88) CES2CES1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250486-A Catalyst comprising a manganese compound, a chelate compound, a base and an unsaturated ketone or ether; controlled molecular weight; odorless; stabile thermal properties when blended with styrene resins GENERAL ELECTRIC COMPANY (US) 1993-10-05 US claimed
CN-1018179-B HYDROLYSIS OF ACTIVATED OLEFINIC KETONES AND ALDEHYDES FRIES & FRIES INC (US) 1992-09-09 CN claimed
EP-0491190-A2 Polyphenylene ether process and resin composition GENERAL ELECTRIC COMPANY (US) 1992-06-24 EP claimed
US-5037943-A Oxidative coupling using alkaline catalysts system of manganese chelate and unsaturated or diketune or vinyl ether GENERAL ELECTRIC CO. (US) 1991-08-06 US claimed
US-4070259-A DIELS-ALDER REACTION PRODUCT, PAINTS, VARNISHES, INKS U C B, SOCIETE ANONYME (BE) 1978-01-24 US claimed
JP-2281013-A None JP disclosed
US-20200223779-A1 CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES SIRRUS, INC. 2020-07-16 US disclosed
WO-2019060188-A1 CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES SIRRUS, INC. (US) 2019-03-28 WO disclosed
EP-2768897-B1 METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS SIRRUS INC (US) 2019-01-23 EP disclosed
EP-3339301-A2 METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS Sirrus, Inc. (US) 2018-06-27 EP disclosed
US-20170342011-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2017-11-30 US disclosed
US-20170342011-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM SIRRUS, INC. 2017-11-30 US disclosed
JP-H02281013-A DIKETONE COMPOUND COPOLYMER CEMEDINE CO LTD 1990-11-16 JP disclosed
EP-0026519-B1 PHOTOGRAPHIC SILVER HALIDE EMULSION MATERIAL CONTAINING AN ANTIFOGGANT PRECURSOR AGFA-GEVAERT N.V. (BE) 1983-08-17 EP disclosed
US-4307175-A Photographic silver halide emulsion material containing an antifoggant precursor AGFA-GEVAERT, N.V. (BE) 1981-12-22 US disclosed
EP-0026519-A1 Photographic silver halide emulsion material containing an antifoggant precursor AGFA-GEVAERT N.V. (BE) 1981-04-08 EP disclosed
US-4154707-A VINYLENEDICARBONYL COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-05-15 US disclosed
US-4105014-A ACIDS AND BASES, EXOTHERMIC ISOMERIZATION BATTELLE DEVELOPMENT CORPORATION (US) 1978-08-08 US disclosed
US-4070259-A DIELS-ALDER REACTION PRODUCT, PAINTS, VARNISHES, INKS U C B, SOCIETE ANONYME (BE) 1978-01-24 US disclosed
US-4004572-A Solar energy collection and retrieval employing reversible photochemical isomerization BATTELLE DEVELOPMENT CORPORATION (US) 1977-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223779-A1 CATALYTIC CYCLE FOR PRODUCTION OF 1,1-DISUBSTITUTED ALKENES ME1, ME3, ME2 CES2 473/4885CES1 101/4885MAPT 3579/4885
US-20170342011-A1 METHYLENE BETA-DIKETONE MONOMERS, METHODS FOR MAKING METHYLENE BETA-DIKETONE MONOMERS, POLYMERIZABLE COMPOSITIONS AND PRODUCTS FORMED THEREFROM B2M, BHMT2, ILK CES2 3604/4885CES1 2860/4885MAPT 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.